Search research articles
Contact Us
Filters
Showing results (11-20 of 81) with videos related to
Page
of 9
Sort By:
Circulation
|
August 13, 2019
A Shocking Deficiency
Erin H Penn, Benjamin A Olenchock, Nicholas A Marston
The New England Journal of Medicine
|
April 29, 2026
Olezarsen for Hypertriglyceridemia and Pancreatitis Risk. Reply
Nicholas A Marston, Brian A Bergmark, Marc S Sabatine
Circulation
|
October 26, 2020
Response by Marston et al to Letter Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism"
Nicholas A Marston, Christian T Ruff, Marc S Sabatine
The New England Journal of Medicine
|
December 30, 2025
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia. Reply
Brian A Bergmark, Nicholas A Marston, Marc S Sabatine
Heart, Lung & Circulation
|
December 6, 2025
Letter to the Editor: "No Time to Waste - Upfront Combination Lipid Lowering Therapy for Post-Acute Coronary Syndromes," Regarding the: National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025 by Brieger et al., Heart Lung Circ. 2025;34:309-397
Ian R Hamilton-Craig, Peter J Psaltis, Nicholas A Marston, et al.
Circulation
|
August 28, 2021
Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL
Nicholas A Marston, Robert P Giugliano, Jeong-Gun Park, et al.
Lancet (London, England)
|
November 13, 2020
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials
Baris Gencer, Nicholas A Marston, KyungAh Im, et al.
Circulation
|
September 19, 2019
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials
Nicholas A Marston, Robert P Giugliano, KyungAh Im, et al.
Journal of the American College of Cardiology
|
January 17, 2024
Per-Particle Cardiovascular Risk of Lipoprotein(a) vs Non-Lp(a) Apolipoprotein B-Containing Lipoproteins
Nicholas A Marston, Giorgio E M Melloni, Sabina A Murphy, et al.
Cardiovascular Ultrasound
|
August 12, 2014
Assessment of left atrial volume before and after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension
Nicholas A Marston, William R Auger, Michael M Madani, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 81) with videos related to
Sort By:
Page
of 9
Circulation
|
August 13, 2019
A Shocking Deficiency
Erin H Penn, Benjamin A Olenchock, Nicholas A Marston
The New England Journal of Medicine
|
April 29, 2026
Olezarsen for Hypertriglyceridemia and Pancreatitis Risk. Reply
Nicholas A Marston, Brian A Bergmark, Marc S Sabatine
Circulation
|
October 26, 2020
Response by Marston et al to Letter Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism"
Nicholas A Marston, Christian T Ruff, Marc S Sabatine
The New England Journal of Medicine
|
December 30, 2025
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia. Reply
Brian A Bergmark, Nicholas A Marston, Marc S Sabatine
Heart, Lung & Circulation
|
December 6, 2025
Letter to the Editor: "No Time to Waste - Upfront Combination Lipid Lowering Therapy for Post-Acute Coronary Syndromes," Regarding the: National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025 by Brieger et al., Heart Lung Circ. 2025;34:309-397
Ian R Hamilton-Craig, Peter J Psaltis, Nicholas A Marston, et al.
Circulation
|
August 28, 2021
Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL
Nicholas A Marston, Robert P Giugliano, Jeong-Gun Park, et al.
Lancet (London, England)
|
November 13, 2020
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials
Baris Gencer, Nicholas A Marston, KyungAh Im, et al.
Circulation
|
September 19, 2019
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials
Nicholas A Marston, Robert P Giugliano, KyungAh Im, et al.
Journal of the American College of Cardiology
|
January 17, 2024
Per-Particle Cardiovascular Risk of Lipoprotein(a) vs Non-Lp(a) Apolipoprotein B-Containing Lipoproteins
Nicholas A Marston, Giorgio E M Melloni, Sabina A Murphy, et al.
Cardiovascular Ultrasound
|
August 12, 2014
Assessment of left atrial volume before and after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension
Nicholas A Marston, William R Auger, Michael M Madani, et al.
Page
of 9